American brachytherapy society (ABS) consensus guidelines for brachytherapy of esophageal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 1, 1997, Pages 127-132

  Gaspar, Laurie E ^a,f   Nag, Subir ^b   Herskovic, Arnold ^c   Mantravadi, Rao ^d   Speiser, Burton ^e  

^a WAYNE STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^f HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Brachytherapy; Esophagus; Guidelines; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; ESOPHAGUS CANCER; HUMAN; METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADENOCARCINOMA; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; PALLIATIVE CARE; PATIENT SELECTION; RADIOTHERAPY DOSAGE; SOCIETIES, MEDICAL;

EID: 0031128390     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00231-9     Document Type: Article

References (30)

1. 1. Al-Sarraf, M.; Pajak, T.; Herskovic, A.; Leichman, L.; Brindle, J. S.; Vaitkevicius, K.; Cooper, J.; Byhardt, R.; Davis, L.; Emami, B. Progress report of combined chemo-radiotherapy (CT-RT) versus radiotherapy (RT) alone in patients with esophageal cancer, an intergroup study. Proc. ASCO 12:197; 1993.
2. 2. Caspers, R. J. L.; Zwinderman, A. H.; Griffioen, G.; Welvaart, K.; Sewsingh, E. N.; Develaar, J.; Leer, J. W. Combined external beam and low dose rate intraluminal radiotherapy in oesophageal cancer. Radiother. Oncol. 27:7-12; 1993.
3. 3. Coia, L. R.; Engstron, P. F.; Paul, A. R.; Stafford, P. M.; Hanks, G. E. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 20:29-36; 1991.
4. 4. Epstein, J. B.; Wong, F. L. W. The efficiacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:693-698; 1994.
5. 5. Fleischman, E. H.; Kagan, A. R.; Bellotti, J. E. Effective palliation for inoperable esophageal cancer using intensive intracavitary radiation. J. Surg. Oncol. 44:234-237; 1990.
6. 6. Fontanesi, J.; Rodriguez, R. R.; Robison, J. C. Intracavitary irradiation as a primary treatment for unresectable esophageal carcinoma. Endocuriether./Hypertherm. Oncol. 5:231-234; 1989.
7. 7. Gaspar, L. Radiation therapy of esophageal cancer: Improving the therapeutic ratio. Sem. Radiat. Oncol. 4:192-201; 1994.
8. 8. Gaspar, L. E.; Kocha, W. I.; Barnett, R.; Dar, A. R.; Ago, C. T.; Inculet, R. A. Cancer of the esophagus: Brachytherapy, external beam radiation and chemotherapy. Cancer J. 6:196-200; 1993.
9. 9. Gaspar, L. E.; Chunlin, Q.; Kocha, W. I.; Coia, L. R.; Herskovic, A.; Graham, M. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report. Int. J. Radiat. Oncol. Biol. Phys. 32 (Suppl. 1):160; 1995.
10. 10. Halvorsen, R. A.; Thompson, W. M. Computed tomographic staging of gastrointestinal tract malignancies, part I. Esophag. Stomach Invest. Radiol. 22:2-16; 1987.
11. 11. Halvorsen, R. A.; Magruder-Habib, K.; Foster, W. L.; Roberts, L.; Postlewait, R. W.; Thompson, W. M. Esophageal cancer staging by CT: Long-term follow-up study. Radiology 161:147-151; 1986.
12. 12. Hareyama, M.; Nishio, M.; Kagami, Y.; Narimatsu, N.; Saito, A.; Sakurai, T. Intracavitary brachytherapy combined with external beam irradiation for squamous cell carcinoma of the thoracic esophagus. Int. J. Radiat. Oncol. Biol. Phys. 24:235-240; 1992.
13. 13. Hay, J. H.; Haylock, B. J.; Flores, A. D.; Evans, K. G.; Finley, R. J.; Nelems, B. Influence of histology on results of pre-op radiotherapy for carcinoma of the lower esophagus and cardia. Clin. Invest. Med. 16(Suppl. B): B118; 1993.
14. 14. Herskovic, A.; Martz, K.; Al-Sarraf, M.; Leichman, L.; Brindle, J.; Vaitkevicius, V.; Cooper, J.; Byhardt, R.; Davis, L.; Emami, B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 326:1593-1598; 1992.
15. 15. Hirokawa, Y.; Akagi, Y.; Kashimoto, K.; Kiriu, H.; Tanaka, S.; Ito, K. Early experience of high dose rate intraluminal irradiation for superficial esophageal cancer. Proceedings of the 4th International Brachytherapy and Remote Afterloading Symposium, May 1995, Palm Beach, FL.
16. 16. Hishikawa, Y.; Izumi, M.; Kurisu, K.; Taniguchi, M.; Kamikonya, N. Esophageal ulceration following high-dose-rate intraluminal brachytherapy for esophageal cancer. Radiother. Oncol. 28:252-254; 1993.
17. 17. Hishikawa, Y.; Kamikonya, N.; Tanaka, S.; Miura, T. Radiotherapy of esophageal carcinoma: Role of high-dose-rate intracavitary irradiation. Radiother. Oncol. 9:13-20; 1987.
18. 18. Hishikawa, Y.; Kuriso, K.; Taniguchi, M.; Kamikonya, N.; Miura, T. High dose rate intraluminal brachytherapy (HDRIBT) for esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 21:1133-1135; 1991.
19. 19. Hishikawa, Y.; Kurisu, K.; Taniguchi, M.; Kamikonya, N.; Miura, T. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother. Oncol. 21:107-114; 1991.
20. 20. Hyden, E. C.; Langholz, B.; Tilden, T.; Lam, K.; Luxton, G.; Astrahan, M.; Jepson, J.; Petrovich, Z. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus. J. Thorac. Cardiovasc. Surg. 96:237-241; 1988.
21. 21. Jager, J. J.; Pannebakker, M.; Rijken, J.; de Vos, J.; Vismans, F. J. Palliation in esophageal cancer with a single session of intraluminal irradiation. Radiother. Oncol. 25:134-136; 1992.
22. 22. Keyes, M.; Haylock, B.; Hay, J. H. An evaluation of pathological effect of pre or post external beam brachytherapy in radical radiotherapy of carcinoma of esophagus. Clin. Invest. Med. 17(4): B115; 1994.
23. 23. Montravadi, R. V. P.; Gates, J. O.; Bajpai, D.; Crawford, J. N.; Trenkner, J. D.; Trenkner, D. A. Combined chemotherapy and external radiation therapy plus intraluminal boost with high dose rate brachytherapy for carcinoma of the esophagus. Endocuriether./Hypertherm. Oncol. 11:223-233; 1995.
24. 24. Nag, S.; Abitbol, A. A.; Andersen, L. L.; Blasko, J. C.; Flores, A.; Harrison, L. B.; Hilaris, B. S.; Marinez, A. A.; Mehta, M.; Nori, D.; Porter, A.; Rossman, K. J.; Speiser, B. L.; Stitt, J. A.; Syed, A. M. N.; Vikram, B. Consensus guidelines for high dose rate remove brachytherapy in cervical, endometrial, and endobronchial tumors. Int. J. Radiat. Oncol. Biol. Phys. 27:1241-1244; 1993.
25. 25. Nori, D.; Allison, R. Prospects for improved treatment results with radiation dose escalation in esophageal cancer. Endocuriether./Hypertherm. Oncol. 9:63-67; 1993.
26. 26. Petrovich, Z.; Langholz, B.; Formenti, S.; Luxton, G.; Astrahan, M. The importance of brachytherapy in the treatment of unresectable carcinoma of the esophagus. Endocuriether./ Hypertherm. Oncol. 5:201-208; 1989.
27. 27. Staar, S.; Mueller, R. P.; Achterrath, W. Intensified treatment for inoperable esophagus cancer: Simultaneous radiochemotherapy combined with HDR intraluminal brachytherapy. Results of a phase II trial. Proc. ASCO 12:223; 1993.
28. 28. Sur, R. K.; Singh, D. P.; Sharma, S. C.; Singh, M. T.; Kochhar, R.; Negi, P. S.; Sethi, T.; Patel, F.; Ayyagari, S.; Bhatia, S. P., et al. Radiation therapy of esophageal cancer: Role of high dose rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 22:1043-1046; 1992.
29. 29. Wang, R. Z.; Zhao, R. O. Combined intracavitary and external radiotherapy for esophageal carcinoma: A prospective randomized clinical trial on 128 patients. Chinese J. Radiat. Oncol. 1:41-43; 1987.
30. 30. Yin, W. B. Brachytherapy of carcinoma of the esophagus in China, 1970-1974 and 1982-1984. In: Martinez, A. A.; Orton, C. G.; Mould, R. F., eds. Brachytherapy: HDR and LDR. Columbia, MD: Nucletron Corp.; 1990:52-56.